Lung cancer and hormone replacement therapy

Lancet. 2010 Jan 9;375(9709):117; author reply 118-9. doi: 10.1016/S0140-6736(10)60040-2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Cadmium / metabolism
  • Carcinogens / metabolism
  • Copper / administration & dosage
  • Copper / metabolism
  • DNA Adducts / drug effects
  • Diet
  • Estrogen Replacement Therapy / adverse effects*
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Liver / metabolism
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / mortality
  • Neovascularization, Pathologic / genetics
  • Neovascularization, Pathologic / metabolism
  • Progesterone / pharmacology
  • Progestins / pharmacology
  • RNA, Messenger / metabolism
  • Randomized Controlled Trials as Topic
  • Smoking / adverse effects
  • Smoking / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Zinc / administration & dosage
  • Zinc / metabolism

Substances

  • Carcinogens
  • DNA Adducts
  • Progestins
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Cadmium
  • Progesterone
  • Copper
  • Zinc